Dr Lori BeachMSc, PhD, FCACB

Assistant Professor


Email: Lori.Beach@iwk.nshealth.ca
Phone: 902-470-3814
Research Topics:
  • Pediatric Laboratory Medicine
  • Maternal Laboratory Medicine
  • Targeted Metabolomics in Biochemical Genetics
  • Public Outreach and Communications in Clinical Biochemistry

As the Clinical Biochemist and Head of Chemistry at IWK Health in Halifax, Nova Scotia, Dr. Lori Beach provides clinical service in laboratory medicine specializing in pediatric and maternal care, including prenatal biochemical screening, newborn screening, core automated chemistry, point-of-care testing, and mass spectrometry/specialized chemistry. Nationally, she is the Division Head of Public Outreach and Communications for the Canadian Society of Clinical Chemists.

As an Assistant Professor in the Department of Pathology at Dalhousie University, her academic interests include mechanisms in Using Labs Wisely, laboratory resource stewardship and quality, training and developing leaders in Clinical Biochemistry and Genetics, research in targeted metabolomics, and translating research to clinical care.


  • BSc Hons (Biology and Chemistry): Wilfrid Laurier University, Waterloo, ON
  • MSc (Molecular Genetics): University of Guelph, Guelph, ON
  • PhD (Biochemistry): University of Toronto, Toronto, ON
  • Clinical Biochemistry Fellowship (FCACB): McMaster University, Hamilton, ON

Selected Publications

A Atkinson, A Albert, E McClymont, J Andrade, L Beach, et al. The Antenatal Serostudies Team, and D Money. (2022) Canadian COVID-19 Population Serological Survey Utilizing Antenatal Serum Samples CMAJ Open. Accepted.

D. Beriault, K. Rodriguez-Capote, K. Hauff, D. Kinniburgh, L. Langman, A. Mattman, D. Konforte, C. Olechuk, L.Beach,  et al (2022) Reduce, Reuse, Recycle: Top 10 Choosing Wisely Canada’s Recommendations for Conserving Laboratory Resources: CWC Recommendations for Conserving Laboratory Resources. Canadian Journal of General Internal Medicine. 17(4). https://doi.org/10.22374/cjgim.v17i4.650

Fung AWS, Mattman A, Wang L, Burton T, Beach LA, Fuezery AK, CSCC Point of Care Testing Interest group. (2021) Intrapartum Fetal Scalp Lactate Testing: Considerations for Implementation and Clinical Decision Making. Journal of Obstetrics and Gynaecology of Canada.43(11):1244-1246.

Beach, L.A., Fung, A., Knauer, M., Shaw, J., and Taher, J. (2021) Commentary: Rapid COVID testing: Speed, Quality and Cost. Can you have all three? Clinical Biochemistry 95:13-14. https://doi.org/10.1016/j.clinbiochem.2021.05.009

Venner, A, Beach, L.A, Fung, A., Huang, Y., Knauer, M., Provencal, M., Shaw, J., and Shea, J. (2020) Quality assurance practices for Point of Care Testing programs: Recommendations by the Canadian Society of Clinical Chemists Point of Care Testing Interest Group. Clinical Biochemistry.  88:11-17. https://doi.org/10.1016/j.clinbiochem.2020.11.008

Bailey, D., Konforte, D., Barakauskas, V.E., Yip, P.M., Kulasingam, V., Abou El Hassan, M., Beach, L.A., et al.

(2020) Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology. Clinical Biochemistry, 86: 1–7. https://doi.org/10.1016/j.clinbiochem.2020.09.005

Van Caeseele, P. (for CPHLN), Bailey, D. (for CSCC – incl. Beach, L.A.), Forgie, S.E. (for AMMIDC), Dingle, T.C. (for CACMID), and Krajden, M. (for COVID-19 ITF) (2020) SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health. CMAJ 192(34)

Simons, J., Beach L., Clark, L. And Kavsak, P.A. (2015) Matrix and bilirubin interference for high-sensitivity cardiac troponin I. Clin Chem Acta 442:49-51.